Benchmarking Pharmaceutical & Biotechnology Team

The Construction Industry Institute (CII) has found that benchmarking is most successful when implemented through a structured, systematic approach. Thus, CII has developed a statistically credible Benchmarking and Metrics (BM&M) program that can be easily integrated into the project delivery process. In the BM&M program, a company’s project performance and practice use are compared against a large number of projects from the industry's most reputable firms.
 
The reports summarize the work performed by CII to develop a Benchmarking Program for the Pharmaceutical and Biotechnology Facilities. The effort resulted in a system that is accessible for all participating companies and allows them to benchmark their projects based on metrics defined specifically for the sector.  Pharmaceutical/biotechnology benchmarking and metrics not only can assist participants in identifying performance gaps and the best approach to improvement, they can also track the progress of the performance improvement journey.